
REGENXBIO Inc.
USD11.85
+0.01 (+0.13%)
CEO
Curran Simpson
IPO Date
2015-09-17
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$11.85
Prev. Close
$11.83
Day Low
$11.63
Day High
$12.24
52W Low
$5.46
52W High
$16.19
Market Cap
$0.61B
Volume
0.99M
| 5 Jun 2026 |
| HC Wainwright & Co. |
| Buy |
| Buy |
| maintain |
| 15 May 2026 | B of A Securities | Buy | Buy | maintain |
| 15 May 2026 | Barclays | Overweight | Overweight | maintain |
| 9 Mar 2026 | HC Wainwright & Co. | Buy | Buy | maintain |
| 6 Mar 2026 | Morgan Stanley | Overweight | Overweight | maintain |
| 10 Feb 2026 | Chardan Capital | Buy | Buy | maintain |
| 10 Feb 2026 | HC Wainwright & Co. | Buy | Buy | maintain |